Compare INGN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGN | MBOT |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.1M | 126.9M |
| IPO Year | 2013 | 2000 |
| Metric | INGN | MBOT |
|---|---|---|
| Price | $5.77 | $1.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $12.00 | $6.33 |
| AVG Volume (30 Days) | 377.8K | ★ 526.8K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.42 | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $348,668,000.00 | $116,887.00 |
| Revenue This Year | $2.22 | N/A |
| Revenue Next Year | $4.55 | $475.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.86 | N/A |
| 52 Week Low | $5.05 | $1.05 |
| 52 Week High | $9.13 | $3.30 |
| Indicator | INGN | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 16.21 |
| Support Level | $5.48 | N/A |
| Resistance Level | $6.73 | $2.21 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 66.67 | 4.14 |
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.